Frantz, A G <br/><br/>
The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.  [electronic resource] 

 -  Federation proceedings  Jun 1978 
 - 2192-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0014-9446 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetonitriles--therapeutic use<br/>Amenorrhea--drug therapy<br/>Bromocriptine--therapeutic use<br/>Dopamine--physiology<br/>Ergolines--therapeutic use<br/>Ergot Alkaloids--therapeutic use<br/>Female<br/>Galactorrhea--drug therapy<br/>Humans<br/>Levodopa--therapeutic use<br/>Pituitary Neoplasms--physiopathology<br/>Pregnancy<br/>Prolactin--blood<br/>Prolactin Release-Inhibiting Factors--physiology